Navigation Links
Mindray's Laptop-size M5 and BS-200 Receive FDA Clearance
Date:3/31/2008

aging device, weighing only six kilograms and combining brilliant color imaging with uncompromised 2D performance. Hand Carried Ultrasound ("HCU") is one of the fastest growing ultrasound segments in the United States and in international markets. The M5 is ideally suited for doctors' offices, clinics and surgery centers that traditionally forego ultrasound imaging equipment due to space and applicable technology constraints.

The company's BS-200 automatic bio-chemistry analyzer also received FDA clearance in the first quarter of 2008 and is available in domestic and international markets. The BS-200 is an automatic low-throughput bio-chemistry analyzer designed to replace semi-automatic bio-chemistry analyzers. It is targeted for hospitals and clinics in rural China as well as small hospitals and labs in international markets. It also serves as a backup machine for large hospitals and labs.

The DC-3 color ultrasound imaging system, designed to have wide applications in abdominal, OB/GYN, endovaginal, cardiac, small parts and pediatric markets, received SFDA approval in the first quarter of 2008. The product is ideally suited for hospitals and clinics seeking to replace black and white ultrasound imaging systems.

New approval pipeline

During the fourth quarter of 2007, the company submitted applications for FDA approval for three of its BeneView series products, including the T5, T6 and T8 multi-parameter patient monitoring devices.

The company expects to receive SFDA approval for its EX55 and EX65 compact anesthesia machines in the second quarter of 2008.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products, and medical
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
2. Western Reserve Heart Care Receives ICANL Nuclear Medicine Accreditation
3. AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award
4. Emageon Receives Best in KLAS Cardiology PACS Award
5. First Health Plans Receive Bridges to Excellence Endorsement and Certification
6. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
7. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
8. Alsius Corporation Receives Regulatory Approval in China and Mexico
9. North American Insurance Leaders, Inc. Receives an Estimate of Deep South 2007 Governing EBITDA
10. Human-Research Protection Program at Fred Hutchinson Cancer Research Center Receives National Accreditation
11. Cystic Fibrosis Foundation Receives Coveted 4-Star Rating for Sound Fiscal Management From Charity Navigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...swire/ -- The Food Allergy & Anaphylaxis Netwo... its new CEO, replacing Founder Anne Munoz-Furlong...to FAAN extensive knowledge of anaphylaxis, a seve...ast six years, as Senior Director of Marketing, sh...r all Dey Pharmaceutical products, including EpiPe...
(Date:12/1/2008)...l disaster relief campaign , , WASHINGTON, ... Cross is asking people across the nation to help .... This holiday season push will put the final touc...ign for Disaster Relief. Already, the campaign has...tember, and the Red Cross hopes to meet its target...
(Date:12/1/2008)...ross Blue Shield of Michigan,provided more than 3...rmation,today to Michigan Attorney General Mike C...about Michigan,s individual health insurance marke... individual health insurance market,and escalatin...last-resort,insurance carrier, in its individual ...
(Date:12/1/2008)...ay help improve treatment for psychiatric problems... Children with lower IQ have an increased risk of ...anxiety disorder and other psychiatric problems as...decades shows. , Lower childhood IQ was also as...ty, as well as an increased risk of having two or ...
Breaking Medicine News(10 mins):Health News:FAAN Names New CEO 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2
...ures are a serious consequence of osteoporosis. Su...,// spinal deformity and hip fracture. According t...ntium ranelate, for women with osteoporosis appear...or a vertebral fracture, according to new research...
...ound exposures during pregnancy may not cause long.../ For the study 2,700 children were evaluated, hal...and half of whom had only one ultrasound exposure ... up at 1, 2, 3, 5 and 8 years of age. While resear...
... young adults who frequently use marijuana may be ... in life //, say researchers based on findings of ...ople between ages 14 and 24 for four years. Partic...predisposition for psychosis, and psychotic sympto...
... shows chronic back pain shrinks the brain by as m...neration of 10 to 20 years of aging.// Using magn...alysis techniques, researchers compared the brain ...ack pain to those of normal participants. The part...
Other Medicine News:
(Date:11/30/2008)... , CHICAGO, Dec. 1 /PRNewswire-USNewswire/ -...ed cerebral blood flow and a greater number of sma...gs presented today at the annual meeting of the Ra... , The study, conducted at the University of N... to compare brain scans of older adults who exerci...
(Date:11/26/2008)...HESTER, Minn., Nov. 26 ...rd are at significantly increased risk of developi... findings of a Mayo Clinic study published this m...merican Academy of Pediatrics. , , The retr...7 patients with strabismus (misaligned eyes) and c...
(Date:11/25/2008)...ults reveal most respondents against expanding sta... , LITTLE FALLS, N.J., Nov. 25 /PRNewswire/ -...n may lower the cardiovascular risk of healthy pat...al statin use in older adults, according to a nati...,212 participants took part in the online poll con...
(Date:11/25/2008)... VEGAS, Nov. 25 CardioVa... CVBT), announced today that it has,dosed the fir...ORD Phase II,clinical trial to treat patients wit...genesis for the treatment of CORonary heart Diseas...nd, placebo-controlled doses in approximately 120,...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 1Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 2Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 3Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 4Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 5Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 6Nastech Appoints MDRNA Inc Directors Strategic Advisory Board 10997 7LMS working with MDAdvantage to minimize obstetrical risks 10995 1LMS working with MDAdvantage to minimize obstetrical risks 10995 2LMS working with MDAdvantage to minimize obstetrical risks 10995 3Coherent Announces Director Slate for Upcoming Annual Meeting 10993 1Coherent Announces Director Slate for Upcoming Annual Meeting 10993 2L 26M Healthcare Communications LLC Hires Scott Karasinski PharmD 3018 1L 26M Healthcare Communications LLC Hires Scott Karasinski PharmD 3018 2
... patients receiving both Tekturna and,Diovan reach...king,either agent alone, EAST HANOVER, N.J., March... have shown patients taking two Novartis cardiovas... Tekturna(R),(aliskiren) and the leading therapy D...ions in blood pressure levels than those,using eit...
...RE)--Mar 26, 2007 - Cytogen,Corporation (NASDAQ: C...resented or published at upcoming major medical me...ical results for QUADRAMET(R),(samarium Sm-153 lex... treatment of metastatic bone disease arising from...data from a study,evaluating the outcomes of prost...
Other Medicine Technology:Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 2Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 3Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 4Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 5Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan 6New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components
The revision knee system for severe joint deterioration with insufficient ligament support.
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results.
The GENESIS II* Total Knee System will define the state of knee implants.
Medicine Products: